Selective Brain Network and Cellular Responses Upon Dimethyl Fumarate Immunomodulation in Multiple Sclerosis

Background: Efficient personalized therapy paradigms are needed to modify the disease course and halt gray (GM) and white matter (WM) damage in patients with multiple sclerosis (MS). Presently, promising disease-modifying drugs show impressive efficiency, however, tailored markers of therapy respons...

Descripción completa

Detalles Bibliográficos
Autores principales: Ciolac, Dumitru, Luessi, Felix, Gonzalez-Escamilla, Gabriel, Koirala, Nabin, Riedel, Christian, Fleischer, Vinzenz, Bittner, Stefan, Krämer, Julia, Meuth, Sven G., Muthuraman, Muthuraman, Groppa, Sergiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6682686/
https://www.ncbi.nlm.nih.gov/pubmed/31417557
http://dx.doi.org/10.3389/fimmu.2019.01779

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6682686/
https://www.ncbi.nlm.nih.gov/pubmed/31417557
http://dx.doi.org/10.3389/fimmu.2019.01779

Ejemplares similares